Murlentamab (Anti-AMHR2)

Ask supplier a question | View on supplier's website

Murlentamab (Anti-AMHR2) is a humanized anti-AMHRII antibody targeting AMHRII. It suppresses tumor growth, stimulates the anti-tumor adaptive immune response through naive macrophage orientation and TAM reprogrammation, in ovarian tumor cells. MW :145.5 KD.

Supplier	Selleck Chemicals
Product #	A2590
Sku #	A2590-1mg
Pricing	1mg, $370.00

Feedback